Global Ganja Report

In the big — and, in nearly half of US states now, successful — drive to legalize cannabis, two major arguments have been brought to bear. First, that public oversight of a legal industry will assure transparency and standards for quality. And secondly, that a taxed industry will be a boon to state and local economies.

But now a disturbing new study from an industry advocacy group in California indicates that the legal cannabis sector faces a challenge in the proliferation of ostensibly legal but in fact unregulated psychoactive “hemp” products.

Legalization in states across the country has led to a reassessment of the word "marijuana." Is it a dated term with racist roots? Many advocates seem to think so. I'm not one of them. Now, Cannabis vs Marijuana: Language, Landscape and Context, a new book by David Paleschuck, dives into the debate. It's a polemic with just one point of view on the cannabis vs. marijuana subject. In the intro, he writes:

Montana this spring defeated the latest effort by anti-freedom forces to roll back legalization in Big Sky Country. And state policy has been tweaked to protect small operators, positioning this inland mountain realm to ride out the dilemmas impacting the cannabis industry on the West Coast.

Dasheeda Dawson is “excited to be back home.”

After a long sojourn as a cannabis patient, advocate and entrepreneur in other states, the Brooklyn native is in her home town as New York City’s first cannabis czar—officially, director of Cannabis NYC, a new office created by Mayor Eric Adams.

In a paradox, New York authorities are finally unleashing the long-anticipated crackdown on the state’s legion and proliferating unlicensed cannabis retailers—while the licensing program continues to be slowed by obstacles, including legal challenges.

Rights for medicinal cannabis users in the workplace have not kept pace with the law in states that have embraced medical and even “recreational” use. Now a case in Vermont may push state and federal authorities alike to close the loopholes that allow workers to be dismissed—and denied unemployment insurance—for using state-legal medicine.

The cannabis industry is globalizing fast, which means changes for mainstays of commercial production in Europe and North America, and new players coming on line from regions such as the Middle East, Southeast Asia and Central America. Here’s a brief overview of a few entries from these categories.

There has been a flurry of vague but lurid reportage about a supposedly addicting and debilitating pseudo-cannabis that is going around in Sierra Leone and other West African countries. This may be akin to products such as K2 and Spice, widely marketed in the US and Europe—but if reports are to be believed, it is far more dangerous.